Compensatory hyperinsulinemia caused by insulin resistance leads to inadequate inhibition of glycogen generation, accelerated protein degradation, reduced protein synthesis, and increased myostatin content, ultimately resulting in skeletal muscle loss (Bonaldo and Sandri 2013; Son et al. 2017). The gene discussed is MSTN; the disease is Hyperinsulinemia.